West Pharmaceutical appoints Michel Lagarde as President and CEO effective August 31, 2026.
West Pharmaceutical Services has entered into an executive employment agreement with Michel Lagarde to serve as President and CEO starting August 31, 2026, with Board appointment. The move signals leadership succession planning for the medical device packaging company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day